SCHEMBL7517040

SCHEMBL7517040

CNC(=O)c1nn(-c2ccccc2)cc1C(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
MAPT P10636 3/20 0.52
GAA P10253 2/20 0.52
POLB P06746 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
PARP1 P09874 1/20 0.51
PARP2 Q9UGN5 1/20 0.51
PARP3 Q9Y6F1 1/20 0.51
KDM4E B2RXH2 2/20 0.51
PKM P14618 1/20 0.51
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HTT P42858 2/20 0.46
AURKA O14965 2/20 0.46
TP53 P04637 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27580619 0.85 ALDH1A1 (0.49) ALDH1A1MAPTGAAPOLBL3MBTL1
SCHEMBL7455491 0.82 MAPT (0.55) ALDH1A1MAPTGAAPOLBL3MBTL1
SCHEMBL29794622 0.81 DGAT1 (0.55) ALDH1A1MAPTGAAPOLBL3MBTL1
SCHEMBL2029527 0.77 JAK2 (0.53) ALDH1A1MAPTPOLBL3MBTL1PARP1
SCHEMBL4903548 0.77 ALDH1A1 (0.60) ALDH1A1MAPTGAAPOLBL3MBTL1
SCHEMBL27560052 0.77 ALDH1A1 (0.49) ALDH1A1MAPTGAAPOLBL3MBTL1
SCHEMBL6256569 0.75 AURKA (0.72) ALDH1A1MAPTGAAKDM4EKMT2A
SCHEMBL7515585 0.75 GAA (0.44) GAAL3MBTL1LMNASMN1; SMN2
SCHEMBL28210218 0.75 PARP1 (0.59) ALDH1A1MAPTGAAPOLBL3MBTL1
SCHEMBL2031958 0.75 PARP1 (0.59) ALDH1A1MAPTGAAPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP claimed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US claimed
US-8623866-B2 2014-01-07 US claimed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP claimed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO claimed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US claimed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A ALDH1A1 271/4885MAPT 4100/4885GAA 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.